Literature DB >> 27069757

Therapy-related myelodysplastic syndrome: a case study.

Masahiro Manabe1, Katsuya Wada2, Dai Momose1, Yasuyoshi Sugano1, Masayuki Hino3, Takahisa Yamane4, Eiwa Ishida5, Ki-Ryang Koh1.   

Abstract

We present a case of therapy-related myelodyspastic syndrome in which the t(3;8)(q26;q24) translocation appeared, even though no chromosomal abnormalities were found at the initial diagnosis of acute myeloid leukemia. To the best of our knowledge, there have only been around 20 reported cases of myeloid malignancies involving t(3;8)(q26;q24). We discuss the characteristics of t(3;8)(q26;q24) along with a review of literature.

Entities:  

Keywords:  Therapy-related myelodyspastic syndrome; dysmegakaryopoiesis; t(3;8)(q26;q24)

Year:  2015        PMID： 27069757      PMCID： PMC4769351     

Source DB:  PubMed          Journal:  Am J Blood Res        ISSN： 2160-1992


  14 in total

1.  EVI1-rearranged acute myeloid leukemias are characterized by distinct molecular alterations.

Authors:  Vincent-Philippe Lavallée; Patrick Gendron; Sébastien Lemieux; Giovanni D'Angelo; Josée Hébert; Guy Sauvageau
Journal:  Blood       Date:  2014-10-20       Impact factor: 22.113

2.  Azacitidine treatment for patients with myelodysplastic syndrome and acute myeloid leukemia with chromosome 3q abnormalities.

Authors:  Anne Wanquet; Thomas Prebet; Céline Berthon; Marie Sebert; Clémence Roux; Austin Kulasekararaj; Jean-Baptiste Micol; Benjamin Esterni; Raphael Itzykson; Sylvain Thepot; Christian Recher; Jacques Delaunay; François Dreyfus; Ghulam Mufti; Pierre Fenaux; Norbert Vey
Journal:  Am J Hematol       Date:  2015-07-14       Impact factor: 10.047

3.  Unique balanced chromosome abnormalities in treatment-related myelodysplastic syndromes and acute myeloid leukemia: report from an international workshop.

Authors:  Harold J Olney; Felix Mitelman; Bertil Johansson; Krzysztof Mrózek; Roland Berger; Janet D Rowley
Journal:  Genes Chromosomes Cancer       Date:  2002-04       Impact factor: 5.006

4.  Cytogenetic and clinical investigations in 76 cases with therapy-related leukemia and myelodysplastic syndrome.

Authors:  A Iurlo; C Mecucci; A Van Orshoven; J L Michaux; M Boogaerts; L Noens; A Bosly; A Louwagie; H Van Den Berghe
Journal:  Cancer Genet Cytogenet       Date:  1989-12

5.  Structural rearrangements of chromosome 3 in 57 patients with acute myeloid leukemia: clinical, hematological and cytogenetic features.

Authors:  Christiane Charrin; Amine Belhabri; Danielle Treille-Ritouet; Gianina Theuil; Jean-Pierre Magaud; Denis Fiere; Xavier Thomas
Journal:  Hematol J       Date:  2002

6.  Centromeric breakage and highly rearranged chromosome derivatives associated with mutations of TP53 are common in therapy-related MDS and AML after therapy with alkylating agents: an M-FISH study.

Authors:  Mette K Andersen; Debes H Christiansen; Jens Pedersen-Bjergaard
Journal:  Genes Chromosomes Cancer       Date:  2005-04       Impact factor: 5.006

7.  Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemia.

Authors:  Pei Lin; L Jeffrey Medeiros; C Cameron Yin; Lynne V Abruzzo
Journal:  Cancer Genet Cytogenet       Date:  2006-04-01

8.  A case of myelodysplastic syndrome with high platelet counts and a t(3;8)(q26;q24).

Authors:  F Mertens; B Johansson; R Billström; L Engquist; F Mitelman
Journal:  Cancer Genet Cytogenet       Date:  1987-07

9.  Chronic inflammatory demyelinating polyneuropathy accompanied by chronic myelomonocytic leukemia: possible pathogenesis of autoimmunity in myelodysplastic syndrome.

Authors:  Atsushi Isoda; Atsushi Sakurai; Yoshiyuki Ogawa; Yuri Miyazawa; Akio Saito; Morio Matsumoto; Morio Sawamura
Journal:  Int J Hematol       Date:  2009-07-09       Impact factor: 2.490

10.  An interphase fluorescence in situ hybridisation assay for the detection of 3q26.2/EVI1 rearrangements in myeloid malignancies.

Authors:  Dolores Bobadilla; Elmon L Enriquez; Georgina Alvarez; Popsie Gaytan; David Smith; Marilyn L Slovak
Journal:  Br J Haematol       Date:  2007-03       Impact factor: 6.998
View more
  1 in total

1.  A case of acute promyelocytic leukemia variant with derivative chromosome 3 der(3)t(3;8) associated with 8q partial gain.

Authors:  Filomena Nozza; Gabriella Vona; Stefania Trino; Fiorella D'Auria; Francesco La Rocca; Vitina Grieco; Luciana Possidente; Luciana De Luca; Pellegrino Musto
Journal:  Mol Cytogenet       Date:  2019-07-05       Impact factor: 2.009
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.